Analyze Diet
Veterinary ophthalmology2025; 29(2); doi: 10.1111/vop.70102

Corneal Squamous Cell Carcinoma Arising From a Conjunctival Graft Scar in a Horse.

Abstract: To describe the case details of an equine corneal squamous cell carcinoma (SCC) arising from the central scar of a previous conjunctival pedicle graft. Methods: An 18-year-old Thoroughbred gelding, showing a progressive increase in diameter, depth, opacity, and pigmentation of a conjunctival pedicle graft scar of the left eye, 34 months after surgery. Methods: Complete ophthalmic examination, standard histologic and immunohistochemical evaluation of an incisional biopsy to formulate a definitive diagnosis. Carbon dioxide (CO) laser photoablation combined with topical mitomycin C treatment. Results: Initial examination with slit-lamp biomicroscopic examination revealed a raised, pale pink and peripherally pigmented, ovoid corneal mass (25 × 20 mm, raised 5 mm) with a smooth to cobblestone contour, paraxial ventral at 6 o'clock of the left eye. Corneal neovascularization extended from the ventral limbus to the graft scar. The remaining ophthalmic examination was unremarkable. Histologic and immunohistochemical evaluation of an incisional biopsy were supportive of a diagnosis of corneal SCC. Two rounds of CO laser photoablation, 10 weeks apart, combined with topical mitomycin C chemotherapy, without surgical debulking, was successful in resolving the neoplastic lesion. The horse was euthanized 4 years later for unrelated reasons, with no evidence of SCC recurrence grossly or histologically. Conclusions: To the authors' knowledge, this is the first report in a horse of a SCC developing at the site of corneal scarring after a conjunctival pedicle graft.
Publication Date: 2025-10-15 PubMed ID: 41090548DOI: 10.1111/vop.70102Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study reports a unique case of corneal squamous cell carcinoma (SCC) developing from the scar of a previous conjunctival graft in a horse’s eye.
  • The paper describes the diagnosis, treatment using CO2 laser photoablation combined with topical chemotherapy, and long-term outcome of the case.

Background and Case Description

  • The subject was an 18-year-old Thoroughbred gelding with a history of conjunctival pedicle graft surgery on the left eye.
  • 34 months post-surgery, a progressive lesion appeared at the central scar site of the graft characterized by increased size, depth, opacity, and pigmentation.
  • Clinical presentation included a raised, pale pink corneal mass with peripheral pigmentation, approximately 25×20 mm in size and 5 mm thick, located ventrally in the cornea at the 6 o’clock position.
  • Corneal neovascularization (new blood vessel formation) extended from the ventral limbus (corneal border) to the graft scar site.
  • Other ophthalmic findings were unremarkable, indicating the lesion was localized without additional widespread eye abnormalities.

Diagnostic Approach

  • A complete ophthalmic examination was performed using slit-lamp biomicroscopy to visualize the lesion’s characteristics.
  • An incisional biopsy of the lesion was obtained for histologic and immunohistochemical analyses to confirm the nature of the tumor.
  • Histology and immunohistochemistry supported the diagnosis of corneal squamous cell carcinoma, identifying malignant epithelial cells typical of SCC.

Treatment Methodology

  • The treatment approach avoided surgical debulking (cutting out the tumor mass) due to potential complications and instead used minimally invasive techniques.
  • Two sessions of carbon dioxide (CO2) laser photoablation were performed 10 weeks apart to vaporize the tumor tissue precisely and minimize damage to surrounding healthy tissue.
  • Topical mitomycin C, a chemotherapeutic agent, was applied to the cornea to inhibit tumor cell proliferation and reduce risk of recurrence.
  • The combined laser and chemotherapy approach successfully resolved the corneal SCC without the need for more invasive surgery.

Outcome and Follow-up

  • The horse was monitored for 4 years after treatment with no clinical or histological evidence of SCC recurrence, indicating a durable remission.
  • Eventually, the horse was euthanized for unrelated reasons, and necropsy confirmed absence of tumor regrowth at the treated site.

Significance and Conclusions

  • This is the first documented case of corneal SCC arising from a conjunctival graft scar in a horse, highlighting a rare but possible late complication of graft surgery.
  • The report demonstrates that non-surgical CO2 laser photoablation combined with topical chemotherapy can be an effective, vision-sparing treatment option for corneal SCC in equine patients.
  • The study underscores the importance of long-term monitoring of graft sites for neoplastic transformation especially in species prone to corneal SCC.
  • Findings contribute to veterinary ophthalmology knowledge by identifying a novel SCC etiology and a successful minimally invasive treatment protocol.

Cite This Article

APA
du Preez S, Lynch B, Lindsay S, Simon O, Ferlini Agne G. (2025). Corneal Squamous Cell Carcinoma Arising From a Conjunctival Graft Scar in a Horse. Vet Ophthalmol, 29(2). https://doi.org/10.1111/vop.70102

Publication

ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 29
Issue: 2

Researcher Affiliations

du Preez, Surita
  • School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia, Australia.
Lynch, Brittany
  • School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia, Australia.
Lindsay, Scott
  • School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia, Australia.
Simon, Olivier
  • School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia, Australia.
Ferlini Agne, Gustavo
  • School of Animal and Veterinary Sciences, University of Adelaide, Roseworthy, South Australia, Australia.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / pathology
  • Horse Diseases / etiology
  • Horse Diseases / diagnosis
  • Horse Diseases / surgery
  • Horse Diseases / therapy
  • Carcinoma, Squamous Cell / veterinary
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / therapy
  • Eye Neoplasms / veterinary
  • Eye Neoplasms / etiology
  • Eye Neoplasms / pathology
  • Male
  • Cicatrix / veterinary
  • Cicatrix / complications
  • Cicatrix / pathology
  • Corneal Diseases / veterinary
  • Corneal Diseases / etiology
  • Corneal Diseases / pathology
  • Mitomycin / therapeutic use
  • Conjunctiva / transplantation
  • Conjunctiva / pathology

References

This article includes 21 references
  1. Lavach J, Severin G. Neoplasia of the Equine Eye, Adnexa, and Orbit: A Review of 68 Cases. Journal of the American Veterinary Medical Association 170, no. 2 (1977): 202–203.
  2. Kaps S, Richter M, Philipp M, Bart M, Eule C, Spiess BM. Primary Invasive Ocular Squamous Cell Carcinoma in a Horse. Veterinary Ophthalmology 8, no. 3 (2005): 193–197.
  3. Mosunic CB, Moore PA, Carmicheal KP. Effects of Treatment With and Without Adjuvant Radiation Therapy on Recurrence of Ocular and Adnexal Squamous Cell Carcinoma in Horses: 157 Cases (1985–2002). Journal of the American Veterinary Medical Association 225, no. 11 (2004): 1733–1738.
  4. Dubielzig RR. Tumors of the Eye. Tumors of Domestic Animals 5th ed., ed. D. J. Meuten (John Wiley & Sons, Incorporated, 2020), 892–922.
  5. Kafarnik C, Rawlings M, Dubielzig RR. Corneal Stromal Invasive Squamous Cell Carcinoma: A Retrospective Morphological Description in 10 Horses. Veterinary Ophthalmology 12, no. 1 (2009): 6–12.
  6. Brooks DE, Plummer CE. Diseases of the Equine Cornea. Equine Ophthalmology 4th ed., ed. B. C. Gilger (Wiley Blackwell, 2022), 253–440.
  7. Surjan Y, Donaldson D, Ostwald P, Milross C, Warren‐Forward H. A Review of Current Treatment Options in the Treatment of Ocular and/or Periocular Squamous Cell Carcinoma in Horses: Is There a Definitive “Best” Practice?. Journal of Equine Veterinary Science 34 (2014): 1037–1050.
  8. Pape U, Gerhards H. Equine Corneal Ulcers ‐ A Retrospective Evaluation of 78 Horses (2008‐2011). Pferdeheilkunde 31, no. 3 (2015): 204–210.
  9. Malalana F, Knottenbelt D, McKane S. Mitomycin C, With or Without Surgery, for the Treatment of Ocular Squamous Cell Carcinoma in Horses. Veterinary Record 167, no. 10 (2010): 373–376.
    doi: 10.1136/vr.c3815google scholar: lookup
  10. Kim E, Park Y. Corneal Squamous Cell Carcinoma Presumed to Arise From Corneal Fibrosis in a Shih‐Tzu Dog. Journal of Veterinary Clinics 35, no. 6 (2018): 311–314.
  11. Rebhun WC. Treatment of Advanced Squamous Cell Carcinomas Involving the Equine Cornea. Veterinary Surgery 19, no. 4 (1990): 297–302.
  12. Clode AB, Miller C, McMullen RJ, Gilger BC. A Retrospective Comparison of Surgical Removal and Subsequent CO2 Laser Ablation Versus Topical Administration of Mitomycin C as Therapy for Equine Corneolimbal Squamous Cell Carcinoma. Veterinary Ophthalmology 15, no. 4 (2012): 254–262.
  13. Khan K, Schafer C, Wood J. Marjolin Ulcer: A Comprehensive Review. Advances in Skin & Wound Care 33, no. 12 (2020): 629–634.
  14. Dugan SJ, Curtis CR, Roberts SM, Severin GA. Epidemiologic Study of Ocular/Adnexal Squamous Cell Carcinoma in Horses. Journal of the American Veterinary Medical Association 198, no. 2 (1991): 251–256.
  15. Singer‐Berk MH, Knickelbein KE, Lounsberry ZT. Additional Evidence for DDB2 T338M as a Genetic Risk Factor for Ocular Squamous Cell Carcinoma in Horses. International Journal of Genomics 2019 (2019): 3610965.
    doi: 10.1155/2019/3610965google scholar: lookup
  16. Hobbs M, Campbell E, Braun KA, Wong L. Multiple Synchronous Acute Marjolin Ulcer: A Report of 2 Cases and Literature Review. JAAD Case Reports 5, no. 6 (2019): 511–513.
  17. Ramirez‐Miranda A, Nakatsu MN, Zarei‐Ghanavati S, Nguyen CV, Deng SX. Keratin 13 Is a More Specific Marker of Conjunctival Epithelium Than Keratin 19. Molecular Vision 17 (2011): 1652–1661.
  18. McMullen RJ. Advancements in Equine Ophthalmic Imaging Enhance Understanding of Ocular and Orbital Anatomy and Disease in Standing Sedated Horses. Journal of the American Veterinary Medical Association 262, no. S2 (2024): S47–S56.
    doi: 10.2460/javma.24.06.0376google scholar: lookup
  19. Kusumesh R, Ambastha A, Kumar S, Sinha BP, Imam N. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia. Cornea 36, no. 3 (2017): 327–331.
  20. Daniell M, Maini R, Tole D. Use of Mitomycin C in the Treatment of Corneal Conjunctival Intraepithelial Neoplasia. Clinical & Experimental Ophthalmology 30, no. 2 (2002): 94–98.
  21. Klefter ON, Rasmussen MLR, Toft PB, Heegaard S. Therapeutic Options for Conjunctival Neoplasia. Expert Review of Ophthalmology 13, no. 1 (2017): 17–31.

Citations

This article has been cited 0 times.